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To further understand the temporal mode and mechanisms 
of coronary restenosis, 229 patients were studied by pro-
spective angiographic follow-up on day 1 and at 1, 3 and 6 
months and 1 year after successful percutaneous translum-
inal coronary angioplasty. Quantitative measurement of 
coronary stenosis was achieved by cinevideodensitometric 
analysis. Actuarial restenosis rate was 12.7% at 1 month, 
43.0% at 3 months, 49.4% at 6 months and 52.5% at 1 
year. 
In 219 patients followed up for 2:3 months, mean 
stenosis diameter was 1.91 ± 0.53 mm immediately after 
coronary angioplasty, 1.72 ± 0.52 mm on day 1, 1.86 ± 
Percutaneous transluminal coronary angioplasty is now 
widely accepted as a nonsurgical revascularization proce-
dure for selected patients with coronary artery disease. Its 
long-term efficacy is limited by coronary restenosis, reported 
in 17 to 40% of patients (1-8). It is well known (4) that most 
cases of restenosis occur within 6 months after coronary 
angioplasty. It is also proposed that some degree of resten-
osis occurs at 4 weeks (9) or even 4 days (10) after coronary 
angioplasty. In these cases, restenosis may simply indicate 
failure of the initial procedure. Most previous studies failed 
to standardize the time of angiographic restudy and to 
document when lesion progression after coronary angio-
plasty really occurred. To answer this question and to 
determine the optimal timing of angiographic restudy, we 
designed a study providing serial angiographic follow-up on 
day 1, and at 1, 3 and 6 months and 1 year after coronary 
angioplasty. 
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0.58 mm at 1 month and 1.43 ± 0.67 mm at 3 months. In 
149 patients followed up for 2:6 months, mean stenosis 
diameter was 1.66 ± 0.58 mm at 3 months and 1.66 ± 0.62 
mm at 6 months. In 73 patients followed up for 1 year, 
mean stenosis diameter was 1.65 ± 0.56 mm at 6 months 
and 1.66 ± 0.57 mm at 1 year. Thus, stenosis diameter 
decreased markedly between 1 month and 3 months after 
coronary angioplasty and reached a plateau thereafter. In 
conclusion, restenosis is most prevalent between 1 and 3 
months and rarely occurs beyond 3 months after coronary 
angioplasty. 
(J Am Coll CardioI1988;12:616-23) 
Methods 
Study patients. Between January and August 1986, 659 
patients underwent coronary angioplasty of native coronary 
arteries at Kokura Memorial Hospital. According to angio-
graphic criteria (> 20% increase in luminal diameter by visual 
estimation) and clinical criteria (improvement in sympto-
matic status without major complications), the procedure 
was considered to be successful in 546 patients (82.9%). 
Major complications included myocardial infarction in 15 
patients (2.3%), emergency bypass surgery iIi 5 (0.8%) and 
death in 3 (0.5%). Two hundred forty-nine patients were 
prospectively enrolled into an angiographic follow-up proto-
colon day 1 and at 1, 3 and 6 months and 1 year after 
coronary angioplasty, regardless of their symptomatic sta-
tus. 
Follow-up angiography was performed on an outpatient 
basis with use of a 5F femoral diagnostic catheter (Angio-
medics). Outpatient catheterization was started at approxi-
mately 9 AM and patients went home after 4 to 5 h of bed 
rest. Selection of patients for serial angiographic follow-up 
was based to a large extent on suitability for outpatient 
catheterization. Those patients who, in the event of compli-
cations, could return to us within 1 h were considered to be 
suitable for outpatient catheterization. The study design is to 
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Table 1. Clinical Characteristics of 526 Patients Undergoing 
Comary Angioplasty 
Serial Angiographic Follow-Up 
Yes No p VlIlue 
No. of patients 229 297 
Age (yr) 6O±1O 62 ± 12 NS 
Gender (male/female) 162/67 218/79 NS 
Previous MI 98 (42.8%) 137 (46.1%) NS 
Acute MI 19 (8.3%) 20 (6.7%) NS 
Previous PTCA 82 (35.8%) 94 (31.6%) NS 
Previous CABG 6 (2.6%) 10 (3.4%) NS 
Multivessel disease 103 (45.0%) 166 (55.9%) <0.05 
Multilesion PTCA 48 (21.0%) 89 (30.0%) <0.05 
CABG = coronary artery bypass grafting; MI = myocardial infarction; 
PTCA = percutaneous transluminal coronary angioplasty. 
a large extent a research procedure and mUltiple catheteri-
zations within a short time period carry risks of arterial 
damage and other potential complications. Outpatient cath-
eterization, however, was performed quite safely by using a 
small 5F catheter. No mortality was associated with this 
procedure. Complications requiring hospitalization included 
a bleeding problem in seven patients (3%), severe angina in 
two (0.9%) and femoral thrombosis in 1 (0.4%). Those 
patients in whom follow-up angiography was possible on an 
outpatient basis were recommended for entry into the study, 
but entry was voluntary. Informed consent was obtained 
from the patients and the responsible relative. 
Serial coronary angiography. Of the 249 patients with 
serial angiography, a high quality angiogram adequate for 
cinevideodensitometric analysis was available in 229 pa-
tients with a total of 288 dilated lesions. In this study, a 5F 
catheter was used for angiographic follow-up. Because the 
use of a 5F catheter for quantitative coronary angiography 
resulted in inadequate visualization in some patients, those 
patients in whom fully opacified angiograms were not ob-
tained were excluded from the study group. The baseline 
characteristics of the patients with or without serial angio-
graphic follow-up were generally similar, although the latter 
group included more patients with multivessel disease and 
multilesion angioplasty (Table O. The study group included 
a significant proportion of patients with previous coronary 
angioplasty, acute myocardial infarction and multivessel 
disease. Because the mechanism of restenosis might be 
different in these subgroups of patients, they were consid-
ered separately. 
Follow-up coronary angiography on day 1 was performed 
in 185 patients with 237 lesions. The femoral artery sheath 
was left in place until the next morning, and coronary 
angiography was performed by way of this indwelling 
sheath. Follow-up angiography at 1 month was performed in 
all 229 patients with a total of288 lesions at 34 ± 6 days after 
coronary angioplasty. Ten patients with a total of 12 lesions 
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withdrew from the study at 1 month; seven of these patients 
had restenosis requiring repeat coronary angioplasty, one 
patient showed disease progression in a nondilated artery 
and two patients refused further study. Thus, follow-up 
angiography at 3 months was performed in 219 patients with 
276 lesions (Group I) at 94 ± 8 days after coronary angio-
plasty. Sixty-seven of these patients, with a total of 88 
lesions, withdrew at 3 months; 63 had restenosis requiring 
repeat coronary angioplasty, 2 died from a noncardiac cause 
and 2 patients refused further study. Thus, follow-up angi-
ography at 6 months was performed in 149 patients with a 
total of 185 lesions (Group II) at 187 ± 8 days after coronary 
angioplasty. Fifteen patients underwent repeat coronary 
angioplasty after the 6 month study. Additional follow-up 
angiography at 1 year was not mandatory but was performed 
in 73 patients with 91 lesions (Group III) at 361 ± 27 days 
after coronary angioplasty. Of these 73 patients, 3 patients 
had refused the restudy at 6 months. 
Angioplasty procedure. Routine antianginal medications 
consisting of long-acting nitrates and calcium channel antag-
onists were continued. At least 1 day before coronary 
angioplasty, aspirin (240 mg three times daily) and dipyrida-
mole (75 mg three times daily) were initiated as antiplatelet 
therapy. Low molecular weight dextran (10% in 5% dex-
trose, 100 mllh) was administered by intravenous infusion 
starting 1 h before the procedure for 5 h. Coronary angio-
plasty was performed by the percutaneous femoral ap-
proach. At the time of arterial access, heparin (10,000 U) 
was injected by way of the femoral artery sheath. Control 
coronary angiography before coronary angioplasty was per-
formed in multiprojections including cranially and caudally 
angulated views, with an 8F guiding catheter (USCI). Imme-
diately before angiography, isosorbide dinitrate (2.5 mg) was 
administered by intracoronary injection as a bolus. To 
control the vasoconstrictive state of epicardial coronary 
arteries, the same protocol regarding isosorbide dinitrate 
was used at all subsequent follow-up studies. Two or three 
balloon inflations for 60 s were routinely performed at 
pressures ranging from 5 to 10 atm. After coronary angio-
plasty, coronary angiography was performed in views nearly 
identical to those used before angioplasty. Patients were 
discharged 2 or 3 days after coronary angioplasty on the 
same medications as before the procedure. 
Measurement of coronary stenosis. Severity of coronary 
stenotic lesions was assessed by quantitative coronary angi-
ography with the use of cinevideodensitometric analysis. A 
Vanguard XR-70 coronary analyzer was utilized for cine-
videodensitometry. Accuracy and variability of cirievideo-
densitometry (11-13) and of this specific instrument (14) 
have been previously validated. A single cine frame was 
selected for analysis. In selecting a cine frame, care was 
taken to display the long axis of the optimally opacified 
arterial segment without significant foreshortening and over-
lapping. The selected cine frame was projected on a 12 in. 
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video screen with twofold magnification, and regions of 
interest were positioned on either side of the catheter shaft, 
the normal arterial segment and the stenotic segment. Lines 
connecting the pairs of regions of interest were generated by 
the microprocessor, and videodensity values for the pixels 
delineated by these lines were measured five times and 
averaged. The portion of the catheter just proximal to the 
primary curve was used as the spatial reference. The nonta-
pered segment most proximal to the stenosis was selected as 
the normal arterial segment. In analyzing the follow-up 
angiograms, care was taken to select as normal a portion of 
the artery nearly identical to this normal arterial segment. 
The stenotic segment was defined as the apparently narrow-
est portion of the artery. During follow-up, the selected 
stenotic segment was not necessarily the same as the initially 
selected segment because the narrowest portion of the artery 
may have changed as a result of restenosis. Percent cross-
sectional area stenosis, the cross-sectional area of the nor-
mal and stenotic segments and the mean diameter of the 
normal and stenotic segments were then calculated. The 
measurements were repeated on three different cine frames 
and the mean values were obtained. 
Definition of restenosis and patient symptomatic status. 
Restenosis was defined as >50% loss of the gain in the 
absolute stenotic diameter assessed by cinevideodensitome-
try. Significant angiographic change at different time inter-
vals was defined as fol1ows: because the type of catheter 
used as the spatial reference is known to influence the 
measurement variability, and because in this study both 8F 
and 5F catheters were used, we selected 22 patients from 
this study group in whom the diagnostic angiogram was 
performed by a 5F catheter and the control angiogram before 
angioplasty by a 8F catheter. To determine the measurement 
variability under a worst case circumstance, paired measure-
ments were performed from the diagnostic and control 
angiograms immediately before coronary angioplasty. The 
mean interval was 9.4 ± 8.4 days. The normal coronary 
diameter was 2.62 ± 0.48 mm at the first measurement and 
2.70 ± 0.54 mm at the second measurement (p = NS). The 
stenotic diameter was 0.98 ± 0.42 and 1.04 ± 0.51 mm, 
respectively (p = NS). The difference between the two 
measurements was 0.08 ± 0.29 mm for the normal diameter 
and 0.06 ± 0.25 mm for the stenotic diameter. A change >2 
SD of difference between duplicate measurements for the 
stenotic diameter (>0.50 mm) was regarded as significant. 
Angiographic evidence of intimal disruption was defined 
according to the National Heart, Lung, and Blood Institute 
Percutaneous Transluminal Coronary Angioplasty Registry 
by 1) an intraluminal filling defect, 2) extraluminal extrava-
sation of contrast material, and 3) linear luminal density or 
luminal staining (15). 
Symptomatic status of the patients during follow-up was 
assessed by the history obtained from the patients immedi-
ately before each follow-up angiogram was taken. Their 
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symptoms at follow-up were subjectively compared with 
those at the time of hospital discharge. Recurrence of 
symptoms was defined as deterioration by at least one angina 
class (Canadian Cardiovascular Society Classification). 
Statistical analysis. Values are expressed as mean values 
± 1 SD except for restenosis rate. Restenosis rate was 
calculated by actuarial analysis (Cutler-Ederer method) and 
expressed as mean ± 1.96 SE (95% confidence limits). 
Categorical variables were analyzed by the chi-square test 
and continuous variables by the Student's t test. A proba-
bility value <0.05 is regarded as significant. 
Results 
Restenosis rate (Table 2). On day 1, coronary restenosis 
was already present in 27 (14.6%) of 185 patients or in 27 
(11.4%) of 237 lesions. The actuarial patient rate of resten-
osis increased markedly between 1 and 3 months (12.7 ± 
4.3% versus 43.0 ± 6.4%) (Fig. 1) and increased only 
modestly after 3 months. In 95 patients with single lesion 
dilation and without prior angioplasty, the restenosis rate 
was 9.5% at 1 month, 41.4% at 3 months, 48.1% at 6 months 
and 53.9% at 1 year. These results were representative of the 
total study population. The total population included a 
. significant proportion of patients with prior coronary angio-
plasty, multilesion angioplasty and acute myocardial infarc-
tion. Because the mechanisms and incidence of restenosis 
might be different in these patients, the lesion restenosis rate 
was analyzed separately in these patient subgroups. The 
trend of markedly increased incidence of restenosis between 
1 and 3 months was similar in these patient subgroups. 
Symptomatic status and restenosis (Table 3). Complete 
revascularization, defined as no residual stenosis >50%, was 
achieved in all 126 patients with single vessel disease and in 
31 of the 103 patients with multivessel disease. At the time of 
hospital discharge, 20 patients (8.7%) were still sympto-
matic. Thirteen (18.1%) of 72 patients with incomplete 
revascularization were symptomatic at the time of hospital 
discharge as compared with only 7 (4.5%) of 157 patients 
with complete revascularization (p < 0.001). 
Recurrence of symptoms was observed in 55 patients 
(24.0%), primarily within the first 3 months (Fig. 2). Seven 
patients (12,7%) had recurrence at 1 month and 36 patients 
(65.5%) at 3 months. Five of these 36 patients required early 
restudy before the scheduled date because of refractory 
angina. Beyond 3 months, 10 patients (18.2%) had recur-
rence at 6 months and 2 patients (3.6%) at 1 year. The degree 
of revascularization had no influence on recurrence of symp-
toms. In patients with multivessel disease, the restenosis 
rate was significantly higher when complete revasculariza-
tion was achieved. Although the restenosis rate was signifi-
cantly higher in the 55 patients with recurrence of symp-
toms, the 174 patients without such recurrence had a 
restenosis rate of 38.9 ± 7.3% at 6 months (Fig. 2). 
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Table 2. Lesion Restenosis Rate in 229 Patients 
I Month 
All 
n 288 
Restenosis rate (%) 11.1±3.6 
Single lesion dilation 
(no prior PTCA) 
n 95 
Restenosis rate (%) 9.5 ± 5.9 
Previously dilated lesions 
n 79 
Restenosis rate (%) 8.9 ± 6.3 
Multilesion dilation 
n 109 
Restenosis rate (%) 13.8 ± 6.5 
Acute myocardial infarction 
n 19 
Restenosis rate (%) 5.3 ± 10 
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Duration of Follow-Up 
3 Months 6 Months I Year 
256 171 138 
39.2 ± 5.7 44.8 ± 5.8 47.6 ± 6.0 
86 54 46 
41.4 ± 10 48.1 ± 10.1 53.9 ± 10.5 
72 52 45 
34.2 ± 10.5 34.2 ± 10.5 34.2 ± 10.5 
92 57 39 
44.3 ± 9.5 47.6 ± 9.6 47.6 ± 9.6 
18 14 12 
26.3 ± 19.8 36.8 ± 21.7 43.5 ± 23 
Restenosis rate was calculated by actuarial analysis and expressed as mean ± 1.96 SE (95% confidence limits). 
n = number of cornary lesions at risk. 
Serial changes in the normal and stenotic coronary artery 
diameter (Fig. 3). There was significant decrease in stenosis 
diameter from immediately after coronary angioplasty to day 
1 (1.91 ± 0.53 versus 1.72 ± 0.52 mm, p < 0.001). Con-
versely, a significant increase in stenosis diameter was 
observed from day 1 to 1 month (1.72 ± 0.52 versus 1.86 ± 
0.58 mm;p < 0.05). Stenosis diameter decreased markedly 
from 1 month to 3 months (Group I) (1.86 ± 0.58 versus 1.43 
± 0.67 mm, p < 0.001). Although the normal diameter did 
not change until 1 month, a significant decrease was ob-
Figure 1. Actuarial coronary restenosis rate in 229 patients with 
serial angiographic follow-up. Restenosis rate was expressed as 
mean ± 1.96 SE (95% confidence limits). The numbers above the 
horizontal line represent the patients at risk at the end of each 
interval. 
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served at 3 months (2.84 ± 0.61 mm immediately after 
coronary angioplasty versus 2.70 ± 0.59 mm at 3 months, p 
< 0.01). In Group II (6 month follow-up), serial diameter 
change showed the same trend as in Group I, although 
Group II included fewer patients with restenosis. Stenosis 
diameter was similar at 3 and 6 months 0.66 ± 0.58 versus 
l.66 ± 0.62 mm; NS). Normal diameter decreased from 2.86 
± 0.64 mm immediately after coronary angioplasty to 2.69 ± 
0.59 mm at 6 months (p < 0.01). In Group III (l year 
follow-up), no significant change in stenosis diameter was 
Table 3. Impact of Degree of Revascularization on Recurrence of 
Symptoms and Rate of Coronary Restenosis in 229 Patients 
No. of patients 
Symptomatic at discharge 
Recurrence of symptoms 
during follow-up 
Patient rate of restenosis (%) 
I mo 
3 mo 
6 mo 
I yr 
Single 
Vessel 
Disease 
126 
3 (2.4%) 
28 (22.2%) 
8.7 ± 4.9 
35.8 ± 8.4' 
40.7 ± 8.6' 
45.0 ± 8.9' 
Multivessel Disease 
Complete Incomplete 
31 72 
4 (12.9%) 13 (\8.1%) 
8 (25.8%) 19 (26.4%) 
19.6 ± 13.9 17.7 ± 8.6:1: 
64.5 ± 16.8t 44.9 ± 11.6+ 
74.2 ± 15.4t 53.8 ± 11.7:1: 
74.2 ± 15.4t 56.2 ± 11.9+ 
*. t, + indicate statistically significant difference: 'single vessel disease vs. 
multivessel disease with complete revascularization; tmultivessel disease 
with complete vs. multivessel disease with incomplete revascularization; 
:j:single vessel disease vs. multivessel disease with incomplete revasculariza-
tion. 
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Figure 2. Actuarial coronary restenosis rate in 229 patients with or 
without recurrent symptom. N = number of patients at risk. 
observed from 6 months to 1 year (1.65 ± 0.56 versus 1.66 ± 
0.57 mm; NS). 
Interval lesion progression and regression. Between im-
mediately after coronary angioplasty to day 1,38 (16.0%) of 
237 lesions showed significant progression and 9 (3.8%) 
showed significant regression as defined by >0.5 mm change 
in stenosis diameter (Fig. 4). Although progression was 
dominant in this interval, correlation between interval pro-
gression and late restenosis assessed at 3 months was poor. 
Late restenosis was observed in 20 (52.6%) of38 lesions with 
progression and in 74 (37.2%) of 199 lesions without progres-
sion (p = NS). 
Between day 1 and 1 month, progression was observed in 
15 (6.3%) of 237 lesions and regression in 45 lesions (19.0%) 
(Fig. 5). Although regression was dominant in this interval, 
progression in this interval was highly predictive of late 
restenosis. Late restenosis was observed in 13 (86.7%) of 15 
lesions with progression and in 81 (36.5%) of 222 lesions 
without progression (p < 0.005). 
The tendency to lesion progression was most prevalent 
between 1 and 3 months (Fig. 6). Beyond 3 months, the trend 
for progression was no longer observed (Fig. 7 and 8). 
Disappearance of intimal disruption. Angiographic evi-
dence of intimal disruption was found in 173 (60.1 %) of 288 
lesions dilated. The presence or absence of intimal disrup-
tion was checked in each of the follow-up angiograms, and 
the time of disappearance of intimal disruption was assessed. 
Excluding 2 lesions of two patients with persistent intimal 
disruption who withdrew from the study at 1 month, 171 
lesions with intimal disruption were followed up. Disappear-
ance of intimal disruption was most frequently found at 1 
month (119 [69.6%] of 171 lesions); in 31 lesions (18.1 %), it 
disappeared at 3 months. In 7 lesions (4.1%) it disappeared 
on day 1, and in 14 lesions (8.2%) it persisted at 3 months. 
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Figure 3. Serial changes in absolute diameter of the normal (open 
circles) and stenotic (closed circles) segments after coronary angio-
pia sty (PTCA). Group I = 3 month angiographic follow-up (a); 
Group II = 6 month follow-up (b); Group III = 1 year follow-up (e). 
Discussion 
Quantitative coronary angiography. Visual estimation of 
lesion severity is known to be associated with wide inter-
and intraobserver variability, especially for those lesions of 
moderate severity (16). In a study of rest enos is, such lesions 
of moderate severity are frequently encountered at fol-
low-up. Although percent diameter stenosis is frequently 
used clinically, this measurement is reported to correlate 
poorly with the physiologic significance of lesions (17). 
Furthermore, because significant changes sometimes occur 
in the adjacent normal coronary segment after coronary 
angioplasty (18), use of percent stenosis in a restenosis study 
has serious shortcomings. Indeed, a significant decrease in 
normal segment diameter was observed during follow-up in 
our study. Thus, a quantitative angiographic study measur-
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Figure 4. Progression and regression of coronary stenosis between 
imme?iate postangioplasty (PTCA) and day 1 with significant angio-
graphic change defined as a >0.50 mm difference in absolute 
diameter of the stenosis. Paired angiograms were obtained in 237 
lesions. 
ing absolute cross-sectional area or diameter is required for 
evaluating restenosis. 
Immediate postangioplasty angiography often shows a 
characteristic hazy and shaggy appearance of the coronary 
lesion, and in analyzing such a lesion, cinevideodensitomet-
ric analysis has an intrinsic advantage. Because most of the 
currently used definitions of restenosis depend on severity of 
stenosis immediately after angioplasty, accurate and repro-
ducible methods of quantitating the severity of coronary 
stenosis on the immediate postangioplasty angiograms are 
essential in a restenosis study. With these viewpoints in 
mind, cinevideodensitometric analysis was used as the 
method of choice for quantitative coronary angiography in 
this study. 
A variety of angiographic definitions of restenosis are 
currently used. The rate of restenosis differs significantly 
Figure 5. Progression and regression of coronary stenosis between 
day 1 and I month postangioplasty (PTCA). Paired angiograms were 
obtained in 237 lesions. 
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Figure 6. Progression and regression of coronary stenosis between I 
and 3 months postangioplasty (PTCA). Paired angiograms were 
obtained in 276 lesions. 
depending on which definition is used. There are as yet only 
a few quantitative angiographic follow-up studies (12,13,19) 
and a widely accepted definition of restenosis has not been 
established. Because the definition of the National Heart, 
Lung, and Blood Institute Percutaneous Transluminal Cor-
onary Angioplasty Registry (>50% loss of the gain) is 
commonly used for percent stenosis and known to be the 
most sensitive definition of restenosis (4,19), we applied this 
definition to absolute stenosis diameter in this study. 
Mechanisms of restenosis. It is well known (4) that most 
cases of restenosis after successful coronary angioplasty 
occur within 6 months after the procedure. Thus, restenosis 
is considered to take place predominantly in the healing 
phase after coronary angioplasty. This finding, in conjunc-
tion with limited numbers of pathologic studies (20-22), 
suggests intimal proliferation of smooth muscle cells as the 
cause of restenosis. 
Figure 7. Progression and regression of stenosis between 3 months 
and 6 months postangioplasty (PTCA). Paired angiograms were 
obtained in 185 lesions. 
3.5 
U :: 
C5 i3 2.0 
uli: i~ 1.5 
1.0 
0.5 
Regression 3.2'.11> 
Progression 6.5'.11> 
0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 
stenotic Dlamster (mm) 
Post PTCA 3 months 
622 NOBUYOSHI ET AL. 
RESTENOSIS AFTER CORONARY ANGIOPLASTY 
3.5 
3.0 
~. I; 2.5 
El~ 2.0 
n. 
il1.S 
iii 
1.0 
0.5 
ResressIon 5.7" 
: ... 
0.5 1.0 1.5 2.0 2.5 3.0 3.5 
stenotic DIameter (nm) 
Post PTCA B months 
Figure 8. Progression and regression of stenosis between 6 months 
and 1 year postangioplasty (PTCA). Paired angiograms were ob-
tained in 88 lesions. 
To validate this pathologic mechanism, this study was 
designed to follow up dilated lesions angiographically during 
the healing phase after coronary angioplasty. Sanders et al. 
(23) reported that exacerbation of stenosis was already 
observed 30 min after coronary angioplasty, and Powelson et 
al. (24) reported that 7 (10%) of70 lesions showed restenosis 
2 days after angioplasty. These studies, however, failed to 
correlate these early changes with late restenosis. DePuey et 
al. (9) reported that abnormal exercise radionuclide ven-
triculography 4 days after coronary angioplasty had an 
accuracy rate of 73% in predicting late restenosis. In the 
present study, early lesion progression at day 1 was ob-
served in 16% of lesions dilated, but these early findings on 
progression did not correlate well with those on late resten-
OSIS. 
Wijns et al. (10) reported that 35 (39%) of 89 patients 
showed lesion restenosis as assessed by exercise redistribu-
tion thallium scintigraphy performed 4 weeks after coronary 
angioplasty. They concluded that some restenosis had al-
ready occurred at 4 weeks after coronary angioplasty in most 
patients with late restenosis. In the present study, lesion 
progression between day 1 to 1 month after coronary angio-
plasty was highly correlated with late restenosis. Restenosis 
at 1 month, however, was relatively uncommon, and at this 
interval, regression was dominant. Serruys et al. (19) re-
ported a 13% angiographic restenosis rate at 30 days, a result 
comparable with our lesion restenosis rate of 11 % at 1 
month. In the majority of our patients, progression was most 
prevalent between 1 and 3 months after coronary angio-
plasty, leading to eventual restenosis. This trend was ob-
served not only in patients with single vessel disease, but 
also in those with multivessel disease, acute myocardial 
infarction and prior coronary angioplasty. Thus, similar 
mechanisms of restenosis were thought to be present in 
these specific subgroups of patients, although the underlying 
pathology might be different. 
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The time of disappearance of angiographically evident 
intimal disruption was assessed in our study. Pathologically, 
intimal cracks or tears are frequently observed after coro-
nary angioplasty, and thus it may be useless to classify 
patients into two subgroups according to the presence or 
absence of angiographic evidence of intimal disruption. 
Angiographically evident intimal disruption, however, can 
be studied by follow-up angiography and it seems reasonable 
to correlate disappearance of intimal disruption with repar-
ative processes after coronary angioplasty. Disappearance 
of intimal disruption was most frequently observed at 1 
month after coronary angioplasty and preceded the frequent 
occurrence of restenosis between 1 and 3 months. Austin et 
al. (21) reported the presence of intimal proliferation of 
smooth muscle cells in a patient examined 17 days after 
coronary angioplasty. Thus it is speculated that, if exces-
sive, reparative processes starting shortly after coronary 
angioplasty can lead to restenosis 1 to 3 months later. Lesion 
regression between day I to 1 month, while reparative 
processes are already operative, could possibly be explained 
by favorable remodeling of the disrupted intima or resolution 
of thrombus. 
The definition of angiographic success in the present 
study was a 20% increase in luminal diameter stenosis rather 
than the more popular definition of a <50% diameter steno-
sis after angioplasty. The inclusion of patients with a residual 
luminal diameter stenosis >50% might well result in a higher 
rate of restenosis. On the other hand, the patients selected 
for serial angiographic follow-up in our study included fewer 
patients with multivessel and multilesion angioplasty, result-
ing in a lower rate of restenosis. Thus, the restenosis rate in 
our study reflects a bias due to patient selection. However, 
serial change in absolute diameter showed a trend similar to 
that of the restenosis rate. Thus, although our study does not 
reflect the true incidence of restenosis, we consider it to be 
representative of the general temporal sequence after coro-
naryangioplasty. 
Optimal timing of angiographic restudy. Whether angio-
graphic restudy is necessary for asymptomatic patients after 
successful coronary angioplasty is still controversial. Most 
previous reports (4,5,7) suggest a lack of clear relation 
between symptoms and angiographic restenosis, although 
Levine et al. (3) reported a good correlation (4.3% in 
asymptomatic patients versus 76% in symptomatic patients). 
The reported incidence of restenosis in asymptomatic pa-
tients varies from 4 to 17% and in symptomatic patients from 
45 to 76%. In our study, the restenosis rate assessed at 6 
months was 39% in asymptomatic patients and 85% in 
symptomatic patients. In view of the unreliable nature of 
patients' symptoms and the high recurrence rate of stenosis 
after coronary angioplasty, follow-up angiography appears 
to be necessary in evaluating the late outcome after success-
ful coronary angioplasty, although exercise radionuclide 
imaging might also be useful. Regarding the optimal timing of 
JACC Vol. 12, No.3 
September 1988:616-23 
angiographic restudy, it might be said that early detection of 
restenosis and confirmation of patency are important con-
siderations. 
A number of reported studies comparing two follow-up 
angiograms with various intervals are available. Kaltenbach 
et al. (2) reported that only 3 of 100 patients without 
restenosis at 3 months after coronary angioplasty showed 
restenosis at 1 year. Rosing et al. (25) reported that in 46 
patients without restenosis at 6 months, mean diameter 
stenosis decreased significantly from 26 ± 16% at 6 months 
to 19 ± 13% at 3 years. Gruentzig et al. (26) reported that, of 
37 patients without restenosis at 6 months, 5 (13.5%) had 
restenosis on the late follow-up angiogram obtained 2 to 7 
years after coronary angioplasty. In our study, significant 
lesion progression was observed in 6.5% of 185 lesions from 
3 months to 6 months and in 9% of 88 lesions from 6 months 
to 1 year. Mean stenosis diameter did not change signifi-
cantly from 3 months to 6 months. These findings clearly 
demonstrate that coronary restenosis after 3 to 6 months is 
rare, although some sporadic progression is possible. Taking 
early detection of rest enos is into consideration, we conclude 
that the optimal timing of angiographic restudy is 3 months 
after successful coronary angioplasty. 
We appreciate the efforts of the Cardiac Catheterization Laboratory staff and 
the secretarial help of Sachiko Toriya. 
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